Abstract
Background Rheumatic heart disease remains a significant public health concern, especially among children in resource-limited settings like Ethiopia. Despite effective prevention strategies, RHD persists due to factors such as poverty and limited healthcare access. Understanding the clinical characteristics and valve lesions of rheumatic heart disease is crucial for improving diagnosis and management.
Objective This study aimed to characterize the clinical features and valve lesions in children with rheumatic heart disease admitted to a tertiary teaching hospital in Eastern Ethiopia.
Methods A hospital-based cross-sectional study was conducted from September 1, 2020, to August 31, 2021, at Hiwot Fana Comprehensive Specialized Hospital. Data were collected from medical records, clinical assessments, echocardiography reports, and laboratory tests. Descriptive statistics were used for analysis.
Results A total of 39 children with rheumatic heart disease were included, predominantly females (71.8%). Shortness of breath (53.9%) and cough (38.5%) were common presenting symptoms. Acute decompensated heart failure (ADHF) was prevalent (89.7%). Mitral regurgitation (94.9%) and aortic regurgitation (66.7%) were frequent valve lesions. Other findings included mitral stenosis (56.4%) and left atrial enlargement (86.1%). Laboratory results showed mean hemoglobin of 10.29 g/dL and mean ESR of 45 mm/hr.
Conclusions This study highlights the burden of RHD in Eastern Ethiopia, with advanced disease at presentation. Mitral and aortic valve lesions were predominant, emphasizing the need for early detection and comprehensive management strategies. Collaboration among healthcare providers and policymakers is essential to address the challenges of RHD in resource-limited settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Haramaya University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance was obtained from Haramaya University College of Health and Medical Sciences Institution Health Research Ethical Review Committee (with ethical approval ref.no: IHRERC/245/2020). An official letter was sent to Hiwot Fana Comprehensive Specialized Hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
